![]() ![]() It’s amazing what strength in numbers can accomplish, especially in the ALS community.”Īural Analytics will be providing tech that can analyze participant’s speech patterns. The Radcliff Study honors his legacy by putting the focus on patients and allowing them to be heard. “He fought tooth and nail to help find a cure for ALS before he passed and more importantly, he cared about other ALS patients, having been through the treacherous diagnosis phase himself and then living with the disease for a year before he passed. “It’s an honor to know Tom’s legacy is continuing on through the study,” said Erin Radcliff, Tom’s wife. The Radcliff study is named after Tom Radcliff, an ALS patient who fought to find a cure for ALS before passing away from the disease. “This is the first time that companies are working in conjunction to capture quantifiable data that could change how ALS and other neurodegenerative diseases like ALS, Alzheimer’s and Parkinson’s are treated and diagnosed.” ![]() “EverythingALS is excited to work with Aural Analytics, FeetMe and ZEPHYRx on this unique study,” said Indu Navar, Founder of the Peter Cohen Foundation and CEO of EverythingALS. Unlike traditional medical tests that need to be done in a medical office, all Radcliff Study components can be completed at home. The research study requires participants to partake in a series of tasks that help track and monitor changes in speech, walking and breathing. The study uses AI, remote patient monitoring technologies, and algorithms to determine possibly clinically meaningful characteristics for persons living with ALS. The Radcliff Study is a multidisciplinary study focused on gait analysis, pulmonary function testing, and speech analytics to make strides towards a digital biomarker. There is not one test or procedure to establish the diagnosis of ALS and there is also no known cure or treatment options available. The Radcliff Study is a novel research-as-a-feasibility study to inform the likelihood of success for a pre-competitive collaboration focused on developing an end-to-end digital alternative for the ALSFRS-R that supports clinically meaningful outcomes tailored for use in ALS. EverythingALS is teaming up with Aural Analytics, a leader in clinical-grade speech analytics, FeetMe, a medical device company that produces smart and connected insoles for improved running, walking and gait analysis, ZEPHYRx, a leading provider of end-to-end remote respiratory monitoring solutions, and a major pharmaceutical company. EverythingALS, a patient-focused non-profit that brings together people living with ALS, caregivers, physicians, researchers, and pharmaceutical companies to collaborate on an open innovation platform using cutting-edge technologies and data science to improve progression measurements for neurological disease like Amyotrophic Lateral Sclerosis (ALS), has initiated a new study, The Radcliff Study, with partners in the quest to find a diagnosis, treatment, and cure for ALS.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |